0.66 -0.03 (-4.35%)

74.71% Fall from 52W High

13,253 XNAS Volume

XNAS 20 Mar, 2025 5:30 PM (EDT)



Insider Trading disclosures for ProMIS Neurosciences Inc.

The latest disclosure was made by Neil Cashman in ProMIS Neurosciences Inc. where a trade of 15,000 Common Shares done at an average price of $1.0 was reported to US exchanges on Feb. 10, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Neil Cashman Director, Chief Scientific Officer Purchase of securities on an exchange or from another person at price $ 0.97 per share. 10 Feb 2025 15,000 16,617 - 1.0 14,595 Common Shares
Max A. Milbury Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2024 70,000 70,000 - - Option (right to buy)
Johanne Kaplan Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2024 175,000 175,000 - - Option (right to buy)
Larry Douglas Altstiel Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2024 175,000 175,000 - - Option (right to buy)
Neil Cashman Director, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2024 200,000 200,000 - - Option (right to buy)
Neil K. Warma Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Oct 2024 1,144,122 1,352,455 - - Option (right to buy)
Neil K. Warma Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Oct 2024 490,338 1,842,739 - - Option (right to buy)
Eugene Williams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Oct 2024 40,000 40,000 - - Option (right to buy)
William W. Wyman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Oct 2024 40,000 40,000 - - Option (right to buy)
Patrick D. Kirwin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Oct 2024 40,000 40,000 - - Option (right to buy)
Madge K. Shafmaster Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Oct 2024 40,000 40,000 - - Option (right to buy)
Joshua Mandel-Brehm Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Oct 2024 40,000 40,000 - - Option (right to buy)
Madge K. Shafmaster Director Purchase of securities on an exchange or from another person at price $ 1.28 per share. 20 Sep 2024 70,000 138,333 - 1.3 89,656 Common Shares
Madge K. Shafmaster Director Purchase of securities on an exchange or from another person at price $ 1.30 per share. 20 Sep 2024 70,000 208,333 - 1.3 91,028 Common Shares
Madge K. Shafmaster Director Purchase of securities on an exchange or from another person at price $ 1.25 per share. 20 Sep 2024 60,000 68,333 - 1.3 75,066 Common Shares
Michael S. Gordon Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.40 per share. 16 Sep 2024 16,292 93,223 - 1.4 22,809 Common Shares, no par value
Michael S. Gordon Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.22 per share. 16 Sep 2024 76,931 76,931 - 1.2 94,071 Common Shares, no par value
Patrick D. Kirwin Director Purchase of securities on an exchange or from another person at price $ 1.25 per share. 14 Aug 2024 10,000 62,983 - 1.2 12,492 Common Shares
Neil Warma K. Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 200,000 208,333 - - Option (right to buy)
Max A. Milbury Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Aug 2023 13,297 14,997 - - Common Shares
Max A. Milbury Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Aug 2023 13,297 13,297 - - Warrants to purchase Common Shares
Gavin T. Malenfant Chief Operating Officer 23 Aug 2023 2,660 2,660 - - Common Shares
Gavin T. Malenfant Chief Operating Officer 23 Aug 2023 2,660 2,660 - - Warrants to purchase Common Shares
Patrick D. Kirwin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Aug 2023 11,000 52,983 - - Common Shares
Patrick D. Kirwin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Aug 2023 11,000 11,000 - - Warrants to purchase Common Shares
Gail M. Farfel Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Aug 2023 53,192 55,192 - - Common Shares
Gail M. Farfel Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Aug 2023 53,192 53,192 - - Warrants to purchase Common Shares
Neil Cashman Director, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Aug 2023 10,643 10,643 - - Warrants to purchase Common Shares
Neil Cashman Director, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Aug 2023 10,643 113,304 - - Common Shares
Eugene Williams Director Purchase of securities on an exchange or from another person at price $ 4.64 per share. 16 Dec 2022 1,000 159,930 - 4.6 4,640 Common Shares
Eugene Williams Director Purchase of securities on an exchange or from another person at price $ 4.65 per share. 16 Dec 2022 1,000 158,930 - 4.7 4,650 Common Shares
Gail M. Farfel Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 4.94 per share. 14 Dec 2022 1,000 2,000 - 4.9 4,940 Common Shares
Patrick D. Kirwin Director Purchase of securities on an exchange or from another person at price $ 4.51 per share. 13 Dec 2022 2,000 27,998 - 4.5 9,020 Common Shares
Patrick D. Kirwin Director Purchase of securities on an exchange or from another person at price $ 4.87 per share. 13 Dec 2022 1,000 25,998 - 4.9 4,870 Common Shares
Eugene Williams Director Purchase of securities on an exchange or from another person at price $ 5.08 per share. 12 Dec 2022 1,000 157,930 - 5.1 5,075 Common Shares
Patrick D. Kirwin Director Purchase of securities on an exchange or from another person at price $ 4.98 per share. 09 Dec 2022 1,000 24,998 - 5.0 4,980 Common Shares
Eugene Williams Director Purchase of securities on an exchange or from another person at price $ 5.49 per share. 07 Dec 2022 1,000 156,930 - 5.5 5,486 Common Share
Gail M. Farfel Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 5.70 per share. 06 Dec 2022 1,000 1,000 - 5.7 5,700 Common Share
Eugene Williams Director Purchase of securities on an exchange or from another person at price $ 5.98 per share. 02 Dec 2022 1,000 155,930 - 6.0 5,980 Common Share
Gail M. Farfel Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Sep 2022 208,334 208,334 - - Option (right to buy)
Patrick D. Kirwin Director Purchase of securities on an exchange or from another person at price $ 5.92 per share. 17 Aug 2022 4,000 41,983 - 5.9 23,680 Common Shares
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures